環亞國際醫療集團(01143.HK)2020年淨虧同比擴大12.59%至1.93億港元
格隆匯 4 月 1日丨環亞國際醫療集團(01143.HK)公吿,截至2020年12月31日止年度未經審核年度業績,收入約為5.95億港元(單位下同),同比減少5.54%;公司擁有人應占虧損約為1.93億港元,同比擴大12.59%;每股基本虧損51.529港仙;不派息。
在嚴峻的經營環境下,集團的電子製造服務及分銷通訊產品分部錄得業績下滑,收入減少約6.3%。
集團啟用雙重策略,從而推動未來收入更快、更穩定地增長。作為該策略的一部分,集團於2021年初正式將由"環亞國際實業有限公司"更名為"環亞國際醫療科技集團有限公司",凸顯集團致力成為醫療科技集團的願景,並提供包括相關產品及服務在內的輔助生殖技術,以滿足亞太區特別是中國內地高端客户的生育需求。
與此同時,集團進入利潤豐厚且住房需求巨大的東南亞房地產市場。為此,集團自2019年下半年起已利用其業務網絡在該地區物色優質房地產項目。當下的疫情限制航空旅行並擾亂供應鏈,當疫情於2021年出現緩解跡象時,公司將進一步加大物色力度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.